NRBO Past Earnings image   This NRBO past earnings page last updated 9/14/2022
NRBO Past Earnings
PeriodPast Earnings DateEarnings
Q2 20228/12/2022-3.600
Q1 20225/13/2022-3.300
Q4 20214/1/2022-5.100
Q3 202111/15/2021-4.800
Q2 20218/16/2021-5.400
Q1 20215/17/2021-4.500
Q4 20204/15/2021-36.000
Q3 202011/13/2020-5.700
Q2 20208/11/2020-4.500
Q1 20205/17/2020-9.000
Q4 20192/17/2020-101.100
NRBO Past Revenue
PeriodPast Earnings DateRevenue
Q2 20228/12/2022NA
Q1 20225/13/2022NA
Q4 20214/1/2022NA
Q3 202111/15/2021NA
Q2 20218/16/2021NA
Q1 20215/17/2021NA
Q4 20204/15/2021NA
Q3 202011/13/2020NA
Q2 20208/11/2020NA
Q1 20205/17/2020NA
Q4 20192/17/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree NRBO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
NeuroBo Pharmaceuticals (NRBO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NRC Past Earnings
NRIX Past Earnings
NSTG Past Earnings
NTLA Past Earnings
NTRA Past Earnings
NTRB Past Earnings
NTUS Past Earnings
NURO Past Earnings
NUVA Past Earnings
NUVL Past Earnings

NRBO Past Earnings Q&A

What was the best and worst NRBO past earnings results?
For NeuroBo Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NRBO past earnings result in our data set was -3.300/share posted in Q1 2022, while the lowest was in Q4 2019 when NRBO posted -101.100/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when NRBO reported NA in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at NA of revenue.

  Suggested answer: There are 11 NRBO past earnings results in our data set.

On this page we presented the NRBO past earnings date information for NeuroBo Pharmaceuticals. Reviewing that NRBO Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2022, when NRBO posted earnings of -3.300/share. Meanwhile the lowest NRBO past earnings result was in Q4 2019, when NRBO posted earnings of -101.100/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when NRBO reported NA in revenue, while the smallest revenue quarter was Q2 2022 when NRBO reported NA in revenue.

Any self directed investor doing their due diligence on NRBO or any other given stock can benefit from researching all of the NeuroBo Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate NeuroBo Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NRBO. Thanks for visiting, and the next time you need to research NRBO past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: IDA Options Chain, Top Ten Hedge Funds Holding KIQ, FAST Videos.

 

NRBO Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.